IC
ALDX icon

IEQ Capital’s Aldeyra Therapeutics ALDX Stock Holding History

IEQ Capital’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$450K Buy
266,518
+122,319
+85% +$536K ﹤0.01% 1355
2025
Q4 		$747K Sell
144,199
-14,954
-9% -$76.8K ﹤0.01% 1154
2025
Q3 		$831K Buy
159,153
+12,299
+8% +$64.1K ﹤0.01% 1081
2025
Q2 		$562K Buy
146,854
+102,709
+233% +$266K ﹤0.01% 1108
2025
Q1 		$254K Buy
+44,145
New +$261K ﹤0.01% 1258

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IEQ Capital's ALDX Position: Q1 2026 in Review

IEQ Capital increased its Aldeyra Therapeutics (ALDX) stake by 85% in Q1 2026, buying an estimated $536K and bringing the position to 266,518 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #1355.

IEQ Capital first reported a position in ALDX in Q1 2025 and has held it in 5 quarters since. The position peaked at $831K in Q3 2025. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • IEQ Capital held 266,518 shares of Aldeyra Therapeutics worth $450K as of Q1 2026.
  • IEQ Capital bought 122,319 Aldeyra Therapeutics shares in Q1 2026, an estimated $536K.
  • Aldeyra Therapeutics made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1355 holding.
  • IEQ Capital first reported a position in Aldeyra Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • IEQ Capital's Aldeyra Therapeutics position peaked at $831K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.